SCHEMBL4884508

SCHEMBL4884508

COc1ccc(C(=O)NC2CCN(C(=O)C(NC(=O)C(CC3CCCC3)CN(O)C=O)C(C)(C)C)CC2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.44
MEN1 O00255 4/20 0.43
ALDH1A1 P00352 3/20 0.43
DPP4 P27487 1/20 0.41
DPP8 Q6V1X1 1/20 0.41
DPP9 Q86TI2 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
TP53 P04637 1/20 0.40
CCR3 P51677 1/20 0.40
MMP1 P03956 1/20 0.39
MMP2 P08253 1/20 0.39
MMP3 P08254 1/20 0.39
MMP8 P22894 1/20 0.39
MMP13 P45452 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
MAPT P10636 1/20 0.39
CTSL P07711 1/20 0.39
CTSS P25774 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4601109 1.00 KMT2A (0.44) KMT2AMEN1ALDH1A1DPP4DPP8
SCHEMBL4603007 0.91 NPC1 (0.41) KMT2AMEN1MMP1MMP13CYP2C19
SCHEMBL4884080 0.91 KMT2A (0.41) KMT2AMEN1CCR3MMP1MMP13
SCHEMBL4902899 0.91 TSHR (0.39) KMT2AMEN1ALDH1A1MMP1MMP13
SCHEMBL4603826 0.91 TSHR (0.39) KMT2AMEN1ALDH1A1MMP1MMP13
SCHEMBL4884110 0.91 KMT2A (0.41) KMT2AMEN1CCR3MMP1MMP13
SCHEMBL4602474 0.90 MMP1 (0.44) KMT2AMEN1MMP1MMP2MMP3
SCHEMBL2793204 0.90 ALDH1A1 (0.46) ALDH1A1MMP1MMP2MMP3MMP8
SCHEMBL4603077 0.90 TSHR (0.41) KMT2AMEN1MMP1MMP13
SCHEMBL2793201 0.90 ALDH1A1 (0.46) ALDH1A1MMP1MMP2MMP3MMP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080234333-A1 Novel Hydroxamic Acid Derivative as Peptide Deformylase Inhibitor and Manufacturing Method Thereof KANG JAE-HOON 2008-09-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080234333-A1 Novel Hydroxamic Acid Derivative as Peptide Deformylase Inhibitor and Manufacturing Method Thereof PDF, PEPD, DHPS KMT2A 1445/4885MEN1 3235/4885ALDH1A1 2155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.